Showing 1 - 8 of 8
Persistent link: https://www.econbiz.de/10001574451
Malaria kills millions of people each year and hundreds of millions more suffer chronic illness. Economic development is inhibited and poverty is perpetuated. Tren and Bate argue that action against malaria is over-centralised and narrowly focused, ignoring local conditions and concerns. Health...
Persistent link: https://www.econbiz.de/10014066541
Persistent link: https://www.econbiz.de/10011408590
Pharmaceutical products can be of poor quality either because they contain zero correct active ingredient (referred to as "counterfeit") or because they contain a non-zero but incorrect amount of the right active ingredient (referred to as "substandard"). While both types of poor-quality drugs...
Persistent link: https://www.econbiz.de/10013036913
Following the Global Pharma Health Fund e.V. Minilab® protocol, we find 9.88% of samples have less than 80% of the correct active ingredient and 41.5% of these failures are counterfeits. Both product registration and chain affiliation of retailers are strong indicators of higher probability to...
Persistent link: https://www.econbiz.de/10012460586
The research-based pharmaceutical industry has a key role in improving access to medicines. By continuing to pursue innovative research and development (R&D), it can improve the availability and effectiveness of drugs. By adopting tiered prices for more drugs — charging people in different...
Persistent link: https://www.econbiz.de/10014152587
Lifesaving drugs donated by taxpayers to developing countries are being stolen, strengthening criminal gangs and undermining donor intent. More worryingly, some donors are not investigating this problem sufficiently; rather, they are moving ahead with programs that have the same inherent...
Persistent link: https://www.econbiz.de/10014152601
Persistent link: https://www.econbiz.de/10014115317